Genomic instability is a fundamental feature of human cancer often resulting from impaired genome maintenance. In prostate cancer, structural genomic rearrangements are a common mechanism driving tumorigenesis. However, somatic alterations predisposing to chromosomal rearrangements in prostate cancer remain largely undefined. Here, we show that SPOP, the most commonly mutated gene in primary prostate cancer modulates DNA double strand break (DSB) repair, and that SPOP mutation is associated with genomic instability. In vivo, SPOP mutation results in a transcriptional response consistent with BRCA1 inactivation resulting in impaired homology-directed repair (HDR) of DSB. Furthermore, we found that SPOP mutation sensitizes to DNA damaging therapeutic agents such as PARP inhibitors. These results implicate SPOP as a novel participant in DSB repair, suggest that SPOP mutation drives prostate tumorigenesis in part through genomic instability, and indicate that mutant SPOP may increase response to DNA-damaging therapeutics. DOI: http://dx.doi.org/10.7554/eLife.09207.001
SPOP mutation leads to genomic instability in prostate cancer
G. Boysen,C. Barbieri,D. Prandi,Mirjam Blattner,Sung-suk Chae,A. Dahija,Srilakshmi Nataraj,Dennis Huang,C. Marotz,Limei Xu,Julie Huang,P. Lecca,S. Chhangawala,Deli Liu,Peng-fei Zhou,A. Sboner,J. D. de Bono,F. Demichelis,Y. Houvras,M. Rubin
Published 2015 in eLife
ABSTRACT
PUBLICATION RECORD
- Publication year
2015
- Venue
eLife
- Publication date
2015-09-16
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-39 of 39 references · Page 1 of 1